Full Text
The Cost-Effectiveness of Brentuximab Vedotin in Hodgkin Lymphoma in Sweden

Abstract

Authors

A. Engstrom

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×